CD22 and acute lymphoblastic leukemia: Conversely, in both experiments, the lentiviral-based overexpression of FL CD22 in CD22ΔE12-positive ALL-1 cell line virtually abrogated its clonogenic growth (8 ± 5 vs. 301 ± 103, linear contrast P-value = 0.0025).